In leukemia, SHP2 mutations contribute to juvenile myelomonocytic leukemia (JMML) and acute myeloid leukemia (AML), promoting uncontrolled proliferation [11]. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.